Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project

BACKGROUND: Pyrazinamide and fluoroquinolones are essential antituberculosis drugs in new rifampicin-sparing regimens. However, little information about the extent of resistance to these drugs at the population level is available. METHODS: In a molecular epidemiology analysis, we used population-bas...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Lancet Infect Dis
Huvudupphovsmän: Zignol, Matteo, Dean, Anna S, Alikhanova, Natavan, Andres, Sönke, Cabibbe, Andrea Maurizio, Cirillo, Daniela Maria, Dadu, Andrei, Dreyer, Andries, Driesen, Michèle, Gilpin, Christopher, Hasan, Rumina, Hasan, Zahra, Hoffner, Sven, Husain, Ashaque, Hussain, Alamdar, Ismail, Nazir, Kamal, Mostofa, Mansjö, Mikael, Mvusi, Lindiwe, Niemann, Stefan, Omar, Shaheed V, Qadeer, Ejaz, Rigouts, Leen, Ruesch-Gerdes, Sabine, Schito, Marco, Seyfaddinova, Mehriban, Skrahina, Alena, Tahseen, Sabira, Wells, William A, Mukadi, Ya Diul, Kimerling, Michael, Floyd, Katherine, Weyer, Karin, Raviglione, Mario C
Materialtyp: Artigo
Språk:Inglês
Publicerad: Elsevier Science ;, The Lancet Pub. Group 2016
Ämnen:
Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5030278/
https://ncbi.nlm.nih.gov/pubmed/27397590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(16)30190-6
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk